These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35900801)

  • 1. Effects and safety of metformin in patients with concurrent diabetes mellitus and chronic obstructive pulmonary disease: a systematic review and meta-analysis.
    Liang Z; Yang M; Xu C; Zeng R; Dong L
    Endocr Connect; 2022 Sep; 11(9):. PubMed ID: 35900801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Vitamin D on Respiratory Function and Immune Status for Patients with Chronic Obstructive Pulmonary Disease (COPD): A Systematic Review and Meta-Analysis.
    Yang H; Sun D; Wu F; Xu X; Liu X; Wang Z; Zhou L
    Comput Math Methods Med; 2022; 2022():2910782. PubMed ID: 35313462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of metformin in treatment of patients with chronic obstructive pulmonary disease: a systematic review.
    Zhu A; Teng Y; Ge D; Zhang X; Hu M; Yao X
    J Thorac Dis; 2019 Oct; 11(10):4371-4378. PubMed ID: 31737323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impacts of metformin on tuberculosis incidence and clinical outcomes in patients with diabetes: a systematic review and meta-analysis.
    Zhang M; He JQ
    Eur J Clin Pharmacol; 2020 Feb; 76(2):149-159. PubMed ID: 31786617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular safety and efficacy of metformin-SGLT2i versus metformin-sulfonylureas in type 2 diabetes: systematic review and meta-analysis of randomized controlled trials.
    Gebrie D; Getnet D; Manyazewal T
    Sci Rep; 2021 Jan; 11(1):137. PubMed ID: 33420333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and safety of metformin alone or as an add-on therapy to insulin in pregnancy with GDM or T2DM: A systematic review and meta-analysis of 21 randomized controlled trials.
    He K; Guo Q; Ge J; Li J; Li C; Jing Z
    J Clin Pharm Ther; 2022 Feb; 47(2):168-177. PubMed ID: 34363237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of metformin use on risk and mortality of hepatocellular carcinoma in diabetes mellitus.
    Li Q; Xu H; Sui C; Zhang H
    Clin Res Hepatol Gastroenterol; 2022 Feb; 46(2):101781. PubMed ID: 34332136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of antidiabetic medications and risk of chronic obstructive pulmonary disease exacerbation requiring hospitalization: a disease risk score-matched nested case-control study.
    Wang MT; Lai JH; Huang YL; Kuo FC; Wang YH; Tsai CL; Tu MY
    Respir Res; 2020 Dec; 21(1):319. PubMed ID: 33267895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of metformin use on the risk and prognosis of colorectal cancer in diabetes mellitus: a meta-analysis.
    Wang Q; Shi M
    Anticancer Drugs; 2022 Feb; 33(2):191-199. PubMed ID: 34620743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Insulin, Metformin, and Glyburide on Perinatal Complications of Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis.
    Wang X; Liu W; Chen H; Chen Q
    Gynecol Obstet Invest; 2021; 86(3):218-230. PubMed ID: 33979807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blended Self-Management Interventions to Reduce Disease Burden in Patients With Chronic Obstructive Pulmonary Disease and Asthma: Systematic Review and Meta-analysis.
    Song X; Hallensleben C; Zhang W; Jiang Z; Shen H; Gobbens RJJ; Kleij RMJJV; Chavannes NH; Versluis A
    J Med Internet Res; 2021 Mar; 23(3):e24602. PubMed ID: 33788700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.
    Hemmingsen B; Schroll JB; Lund SS; Wetterslev J; Gluud C; Vaag A; Sonne DP; Lundstrøm LH; Almdal T
    Cochrane Database Syst Rev; 2013 Apr; (4):CD009008. PubMed ID: 23633364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin and second- or third-generation sulphonylurea combination therapy for adults with type 2 diabetes mellitus.
    Madsen KS; Kähler P; Kähler LKA; Madsbad S; Gnesin F; Metzendorf MI; Richter B; Hemmingsen B
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012368. PubMed ID: 30998259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-IL-5 therapies for chronic obstructive pulmonary disease.
    Donovan T; Milan SJ; Wang R; Banchoff E; Bradley P; Crossingham I
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013432. PubMed ID: 33295032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of metformin on clinical outcomes among men with prostate cancer: a systematic review and meta-analysis.
    Raval AD; Thakker D; Vyas A; Salkini M; Madhavan S; Sambamoorthi U
    Prostate Cancer Prostatic Dis; 2015 Jun; 18(2):110-21. PubMed ID: 25667109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Metformin Use with Asthma Exacerbation in Patients with Concurrent Asthma and Diabetes: A Systematic Review and Meta-Analysis of Observational Studies.
    Wen L; Zhong W; Chai Y; Zhong Q; Gao J; Guan L; Zhang Mengzhi ; Huaiquan L; Haiyang Y; Qingxue W; Changfu Y; Yunzhi C
    Can Respir J; 2020; 2020():9705604. PubMed ID: 32831980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitus.
    Li T; Providencia R; Mu N; Yin Y; Chen M; Wang Y; Liu M; Yu L; Gu C; Ma H
    Cardiovasc Diabetol; 2021 Jan; 20(1):30. PubMed ID: 33516224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting the length of stay and hospital readmission rates after an acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis.
    Wang Q; Pei G; Chen L; He Z
    Ann Transl Med; 2022 Feb; 10(4):175. PubMed ID: 35280353
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.